Richard A. Heyman, Director: Oric Pharmaceuticals ORIC Planned sale · Filed 10/01

Trade details

Type: Planned sale notice
Stock: Oric Pharmaceuticals ORIC
Person: Richard A. HeymanDirector
Planned sale date: 26/10/01
Filed: 26/10/01

More to sell after $161.1K in 3 months

Oric Pharmaceuticals trades, last 26 weeks

What else happened in Oric Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$84K
7,000 sh
$84K
Filed 07/06
Traded 07/06
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$76.8K
6,400 sh
$76.8K
Filed 07/06
Traded 07/06
Richard A. HeymanDirector
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$32.2K
1,230 sh
$32.2K
Filed 02/19
Traded 02/17